Impact of Structured Medication Therapy Management on Type 2 Diabetes Mellitus and Hypertension as Associated Co-Morbidity

Abstract

Background: Effective management strategies using pharmacological and lifestyle interventions can improve patient outcomes among those with hypertension and type 2 diabetes mellitus (T2DM). Objective: To understand the efficacy of an integrated intervention strategy to enhance clinical outcomes in hypertension and T2DM patients following 24 follow-ups. Methods: RCT of 96 participants was utilized with intervention and control groups. A combination of pharmacological adjustment, lifestyle modification, and patient education was given to the intervention group, and standard care was given to the control group. The primary outcome measures were the systolic blood pressure (SBP), diastolic blood pressure (DBP), random blood sugar (RBS) and glycated haemoglobin (HbA1c). Paired t-tests and ANOVA were performed to do statistical analysis. Results: The reduction of SBP (mean reduction of 20.36 mmHg) DBP (mean reduction of 7.17 mmHg), RBS (mean reduction of 44.26 mg/dL) and HbA1c (mean decrease of 0.89%, p < 0.001) was found in the intervention group, being reduced significantly compared to that in the control group. Although the improved age and sex balance ensured the reliability and generalizability of the findings, the improvements were consistent at all levels of severity. Conclusion: Integrated intervention strategy produced an effect on blood pressure, glycemic control, and clinical events that were greater than with standard care. These findings have important implications for the multidimensional treatment approaches to manage hypertension and T2DM. Finally, the study serves to lay the foundation for future research on integrated models to optimize patient outcomes and health care efficiency.

Keywords: Hypertension, Medication Therapy Management, Patient Outcomes, Quality of Life, Type 2 Diabetes Mellitus

Downloads

Download data is not yet available.

References

Al-Jawaldeh, A., & Abbass, M. M. S. (2022). Unhealthy Dietary Habits and Obesity: The Major Risk Factors Beyond Non-Communicable Diseases in the Eastern Mediterranean Region. Frontiers in Nutrition, 9. Https://Doi.Org/10.3389/Fnut.2022.817808
Almeida, D. M., Santos-de-Araújo, A. D., Júnior, J. M. C. B., Cacere, M., Pontes-Silva, A., Costa, C. P., ... & Bassi-Dibai, D. (2024). The best internal structure of the Diabetes Quality of Life Measure (DQOL) in Brazilian patients. BMC Public Health, 24(1). https://doi.org/10.1186/s12889-024-18090-z
Asif, Z., Virk, A. A., Alvi, A. S., Bibi, I., & Iqbal, M. Evaluating Patient Perceptions of Pharmacist-Led Medication Therapy Management in Hypertension Management. Journal of Pharmaceutical Research International, 36(10). 1-13. https://doi.org/10.9734/jpri/2024/v36i107584
Axon, D. R., Johnson, M., Abeln, B., Forbes, S., Anderson, E. J., Taylor, A. M., ... & Hall-Lipsy, E. (2022). An academic-community collaboration to deliver medication therapy management (MTM) services to patients living in rural counties of a Southwestern State in the United States. Journal of Pharmacy Practice, 35(5), 691-700. https://doi.org/10.1177/08971900211000219
Balestroni, G., & Bertolotti, G. (2012). EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Archives for Chest Disease, 78(3). 155-159.https://doi.org/10.4081/MONALDI.2012.121
Bheenaveni, R. (2016). Indigenous Healthcare: Determinants and Practices. IOSR Journal of Humanities and Social Science, 21(08), 19–22. https://doi.org/10.9790/0837-2108111922
Caballero, A. E. (2018). The “A to Z” of managing type 2 diabetes in culturally diverse populations. Frontiers in Endocrinology, 9. https://doi.org/10.3389/FENDO.2018.00479
Chaudhary, B., & Chaudhary, A. (2022). Hypertension and Lifestyle Modifications: Beyond Controversy. Journal of Advances in Medicine and Medical Research, 34(21) 337-342. https://doi.org/10.9734/jammr/2022/v34i2131552
Chow, C. K., Chow, C. K., & Gupta, R. (2019). Blood pressure control: a challenge to global health systems. The Lancet. https://doi.org/10.1016/S0140-6736(19)31293-0
Chung, I. M., Rajakumar, G., Subramanian, U., Venkidasamy, B., Khanna, V. G., & Thiruvengadam, M. (2020). Insights on the current status and advancement of diabetes mellitus type 2 and to avert complications: An overview. Biotechnology and Applied Biochemistry, 67(6), 920-928. https://doi.org/10.1002/bab.1853
Deng, Z. J., Gui, L., Chen, J., Peng, S. S., Ding, Y. F., & Wei, A. H. (2023). Clinical, economic and humanistic outcomes of medication therapy management services: A systematic review and meta-analysis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1143444
Dey, S., Mukherjee, A., Pati, M. K., Kar, A., Ramanaik, S., Pujar, A., ... & N, S. (2022). Socio-demographic, behavioural and clinical factors influencing control of diabetes and hypertension in urban Mysore, South India: a mixed-method study conducted in 2018. Archives of Public Health, 80(1). https://doi.org/10.1186/s13690-022-00996-y
Evans, M. D., Welsh, Z. K., & Seibold, A. (2022). Reductions in HbA1c with flash glucose monitoring are sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies. Diabetes Therapy, 13(6), 1175–1185. https://doi.org/10.1007/s13300-022-01253-9
Ferreri, S. P., Hughes, T. D., & Snyder, M. E. (2020). Medication therapy management: current challenges. Integrated Pharmacy Research and Practice, 71-8, 2020(9). https://doi.org/10.2147/iprp.s179628
Gupta, R., Gaur, K., Ahuja, S., & Anjana, R. M. (2024). Recent studies on hypertension prevalence and control in India 2023. Hypertension Research, 47(6), 1445-1456. https://doi.org/10.1038/s41440-024-01585-y
Harding, J. L., Pavkov, M. E., Magliano, D. J., Shaw, J. E., & Gregg, E. W. (2019). Global trends in diabetes complications: a review of current evidence. Diabetologia, 62, 3-16. https://doi.org/10.1007/s00125-018-4711-2
Kaur, P., Kunwar, A., Sharma, M., Durgad, K., Gupta, S., & Bhargava, B. (2023). The India Hypertension Control Initiative–early outcomes in 26 districts across five states of India, 2018–2020. Journal of Human Hypertension, 37(7), 560-567. https://doi.org/10.1038/s41371-022-00742-5
Kelley, G. A., Kelley, K. S., & Stauffer, B. L. (2022). Walking and resting blood pressure: an inter-individual response difference meta-analysis of randomized controlled trials. Science Progress, 105(2), https://doi.org/10.1177/00368504221101636
Kolb, H., & Martin, S. (2017). Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes. BMC Medicine, 15, 1-11.https://doi.org/10.1186/s12916-017-0901-x
Kumar, A., Gangwar, R., Ahmad Zargar, A., Kumar, R., & Sharma, A. (2024). Prevalence of diabetes in India: A review of IDF diabetes atlas 10th edition. Current Diabetes Reviews, 20(1), 105-114. https://doi.org/10.2174/1573399819666230413094200
Li, J., Yang, F., Wang, J., & Tao, Y. (2022). Effect of community‐based nurse‐led support intervention in the reduction of HbA1c levels. Public Health Nursing, 39(6), 1318-1333, https://doi.org/10.1111/phn.13119
Li, N., Song, J. F., Zhang, M. Z., Lv, X. M., Hua, H. L., & Chang, Y. L. (2023). Impact of medication therapy management (MTM) service model on multi-morbidity (MMD) patients with hypertension: a pilot RCT. BMC Geriatrics, 23(1). https://doi.org/10.1186/s12877-023-03725-4
Liu, J., Ren, Z. H., Qiang, H., Wu, J., Shen, M., Zhang, L., & Lyu, J. (2020). Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health, 20, 1-12. https://doi.org/10.1186/s12889-020-09502-x
Ma, J., & Chen, X. (2022). Advances in pathogenesis and treatment of essential hypertension. Frontiers in Cardiovascular Medicine, 9. https://doi.org/10.3389/fcvm.2022.1003852
Marupuru, S., Roether, A., Guimond, A. J., Stanley, C., Pesqueira, T., & Axon, D. R. (2022, June). A systematic review of clinical outcomes from pharmacist provided medication therapy management (MTM) among patients with diabetes, hypertension, or dyslipidemia. In Healthcare (Vol. 10, No. 7, p. 1207). MDPI. https://doi.org/10.3390/healthcare10071207
Mishra, R., Sharma, S. K., Verma, R., Kangra, P., Dahiya, P., Kumari, P., ... & Kant, R. (2021). Medication adherence and quality of life among type-2 diabetes mellitus patients in India. World Journal of Diabetes, 12(10).1740-1749. https://doi.org/10.4239/WJD.V12.I10.1740
Moon, S. J., Lee, W. Y., Hwang, J. S., Hong, Y. P., & Morisky, D. E. (2017). Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PloS One, 12(11). https://doi.org/10.1371/journal.pone.0196138
Mugisha, E. (2025). Management and therapeutic intervention for hypertension: A comprehensive review. IDOSR Journal of Applied Sciences, 9(3), 12-16. https://doi.org/10.59298/idosrjas/2024/9.3.121600
Oparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cífková, R., Dominiczak, A. F., Grassi, G., Jordan, J., Poulter, N. R., Rodgers, A., & Whelton, P. K. (2018). Hypertension. Nature Reviews Disease Primers, 4(1). https://doi.org/10.1038/nrdp.2018.14
Ralapanawa, U., Nanayakkara, N., Jayawickreme, K. P., Wickramasurendra, N., & Tennakoon, S. (2019). Analysis and identification of symptoms and risk factors in a cohort of chronic hypertensive patients in a tertiary care hospital in Sri Lanka. Clinical and Experimental Hypertension, 41(5), 409-413. https://doi.org/10.1080/10641963.2018.1501055
Ranasinghe, P., Jayawardena, R., Gamage, N., Sivanandam, N., & Misra, A. (2021). Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Annals of Epidemiology, 58, 128-148. https://doi.org/10.1016/J.ANNEPIDEM.2021.02.016
Shin, Y., & Chang, E. (2024). Consumption of fruits, vegetables, and nuts influences the association between serum uric acid and hypertension in Korean adults: A nationwide survey (KNHANES 2016–2021). Asia Pacific Journal of Clinical Nutrition, 34(1), 13–24. https://doi.org/10.6133/apjcn.202502_34(1).0013
Singaraju, D. K., & Dattu, M. S. (2019). Study of prevalence and associated risk factors for hypertension in a teaching hospital. Journal of Evidence Based Medicine and Healthcare, 6(30), 2068–2071. https://doi.org/10.18410/jebmh/2019/420
Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., ... & Magliano, D. J. (2022). IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Research and Clinical Practice, 183. . https://doi.org/10.1016/j.diabres.2021.109119
Taher, M. I. M., & Ibrahim, R. H. (2023). Knowledge, attitudes, and practice of university's employees about complementary and alternative medicine (CAM). Informatics in Medicine Unlocked, 37, 101184. https://doi.org/10.1016/j.imu.2023.101184
Treciokiene, I., Postma, M. J., Nuygen, T., Fens, T., Petkevicius, J., & Taxis, K. (2017). A Systematic Review on lifestyle change interventions performed by health care professionals targeting blood pressure in hypertensive patients. Value in Health, 20(9). https://doi.org/10.1016/J.JVAL.2017.08.1161
Vijayakumar, V., Mavathur, R., & Sharma, M. N. (2018). Ethnic disparity and increased prevalence of type 2 diabetes among South Asians: aetiology and future implications for diabetes prevention and management. Current Diabetes Reviews, 14(6), 518-522. https://doi.org/10.2174/1573399813666170915132935
Viswanathan, M., Kahwati, L. C., Golin, C. E., Blalock, S. J., Coker-Schwimmer, E., Posey, R., & Lohr, K. N. (2015). Medication therapy management interventions in outpatient settings: a systematic review and meta-analysis. JAMA Internal Medicine, 175(1), 76-87. https://doi.org/10.1001/jamainternmed.2014.5841
Wang, Y.-C., & Yang, H.-Y. (2025). Application of home blood pressure monitoring in hypertension management. Journal of Nursing, 72(1), 13–20. https://doi.org/10.6224/jn.202502_72(1).13
Yamane, S. S., De Gagne, J. C., Riggs, A., Kimberly, G. D., & Holye, M. (2020). Assessment of a patient-centered initiative to improve hypertension management for adults with comorbid type 2 diabetes at a free clinic in the rural south. Nursing Forum, 55(3), 348–355. https://doi.org/10.1111/NUF.12434
Zappa, M., Golino, M., Verdecchia, P., & Angeli, F. (2024). Genetics of hypertension: from monogenic analysis to GETomics. Journal of Cardiovascular Development and Disease, 11(5). https://doi.org/10.3390/jcdd11050154
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., ... & Breckenkamp, J. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957-980. https://doi.org/10.1016/s0140-6736(21)01330-1
Statistics
384 Views | 264 Downloads
How to Cite
Ugandar, R., Kumar, G., Akshaya, A., Gudipati, L., Kavya, K. and Naik, K. (2025) “Impact of Structured Medication Therapy Management on Type 2 Diabetes Mellitus and Hypertension as Associated Co-Morbidity”, International Journal of Advancement in Life Sciences Research, 8(2), pp. 95-112. doi: https://doi.org/10.31632/ijalsr.2025.v08i02.008.